Investorideas.com - #Cannabisstocks: Organigram (TSXV: $OGI.V) (OTCQB: $OGRMF) signs supply agreement with Nova Scotia Liquor Corporation
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Cannabis, marijuana and Hemp stock news from Investorideas.com plus daily cannabis #potcasts - Investor Ideas #Potcasts #Cannabis News and Stocks on the Move
Friday, August 24, 2018
Investorideas.com - Good #Trading with #Stock Analyst Guru Richard Lazarow - Support and Resistance trading Ep20: #cannabisstocks #trading #ETFs #sweepstakes #goodtrading
Investorideas.com - Good #Trading with #Stock Analyst Guru Richard Lazarow - Support and Resistance trading Ep20: #cannabisstocks #trading #ETFs #sweepstakes #goodtrading
Good #Trading with #Stock Analyst Guru
Richard Lazarow- Support and Resistance Trading Ep20: #cannabisstocks
trading #ETFs #sweepstakes #goodtrading
Richard Lazarow- Support and Resistance Trading Ep20: #cannabisstocks
trading #ETFs #sweepstakes #goodtrading
Learn
how to trade like a Wall Street Analyst
how to trade like a Wall Street Analyst
New York, NY, Delta BC – New York, NY,
Delta BC – August 24, 2018 – Investorideas.com (www.investorideas.com), a global news source
covering leading sectors issues today’s episode of its educational trading
podcast featuring the founder of Stock Analyst Guru, LLC, Richard Lazarow.
Delta BC – August 24, 2018 – Investorideas.com (www.investorideas.com), a global news source
covering leading sectors issues today’s episode of its educational trading
podcast featuring the founder of Stock Analyst Guru, LLC, Richard Lazarow.
Episode
20: Support and Resistance #trading: #cannabisstocks
#trading #ETFs #sweepstakes #goodtrading
20: Support and Resistance #trading: #cannabisstocks
#trading #ETFs #sweepstakes #goodtrading
Hear
the podcast:
the podcast:
About
the podcast: Investorideas.com exclusive podcast
series with the founder of Stock Analyst Guru, Richard Lazarow.
the podcast: Investorideas.com exclusive podcast
series with the founder of Stock Analyst Guru, Richard Lazarow.
Richard has over 10 years of institutional
equity experience as a stock analyst / portfolio manager and stock trader,
managing stock positions at Hedge Funds and other Funds in NYC. In this weekly
podcast series you will hear his insights on
learning how to invest based on the most important aspects of investing,
identifying Support & Resistance, and Trend. These top-down Market updates
and sector close-ups are extremely useful in helping to keep investors more
fully invested in stocks and in the correct sectors ONLY while the Market and a
stock’s Sector are healthy (i.e. going UP), and are just a small part of his
valuable training. For the full educational experience you can check out www.stockanalystguru.com.
equity experience as a stock analyst / portfolio manager and stock trader,
managing stock positions at Hedge Funds and other Funds in NYC. In this weekly
podcast series you will hear his insights on
learning how to invest based on the most important aspects of investing,
identifying Support & Resistance, and Trend. These top-down Market updates
and sector close-ups are extremely useful in helping to keep investors more
fully invested in stocks and in the correct sectors ONLY while the Market and a
stock’s Sector are healthy (i.e. going UP), and are just a small part of his
valuable training. For the full educational experience you can check out www.stockanalystguru.com.
Investor ideas reminds all listeners to
read our disclaimers and disclosures on the Investorideas.com website and this
podcast is not an endorsement to buy products or services or securities.
Investors are reminded all investment involves risk and possible loss of
investment.
read our disclaimers and disclosures on the Investorideas.com website and this
podcast is not an endorsement to buy products or services or securities.
Investors are reminded all investment involves risk and possible loss of
investment.
Enter Trading Sweepstakes Here: https://www.stockanalystguru.com/membership-account/membership-checkout/?level=3
Stock Analyst Guru is offering a Sweepstakes to all
Investor Ideas members, subscribers, and friends. Just sign up for the FREE Fundamental Curriculum
(no CC needed) and that enters you into the drawing, with 1st prize being a
discount code for $2900 OFF of our entire Curriculum, bringing the final price
to ONLY $97, which is about 97% off!
Investor Ideas members, subscribers, and friends. Just sign up for the FREE Fundamental Curriculum
(no CC needed) and that enters you into the drawing, with 1st prize being a
discount code for $2900 OFF of our entire Curriculum, bringing the final price
to ONLY $97, which is about 97% off!
Second place will be a discount code for $2700 off
(final price: $297), and 3rd-5th places a code for $2500 off (final price:
$497)!
(final price: $297), and 3rd-5th places a code for $2500 off (final price:
$497)!
Stock Analyst Guru,
LLC - Richard Lazarow
LLC - Richard Lazarow
Learn how to trade like a Wall Street
Analyst: Download Stock Analyst Guru’s free trading curriculum and be
automatically entered into the sweepstakes
Analyst: Download Stock Analyst Guru’s free trading curriculum and be
automatically entered into the sweepstakes
To help you follow and track sectors
Investorideas.com has created stock directories of publicly traded stocks for
investors to use as a research tool to start trading and investing.
Investorideas.com has created stock directories of publicly traded stocks for
investors to use as a research tool to start trading and investing.
Visit http://www.investorideas.com/membership/ to learn more about our stock directories in
leading sectors
leading sectors
About
Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts
and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner
and Podcast, Play
by Play sports and stock news column, Investor Ideas
#Potcasts #Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change
Podcast and the Stock Guru daily podcast
on Support and Resistance Trading.
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts
and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner
and Podcast, Play
by Play sports and stock news column, Investor Ideas
#Potcasts #Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change
Podcast and the Stock Guru daily podcast
on Support and Resistance Trading.
The
Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio
and Google Play Music.
Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio
and Google Play Music.
Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, contents creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers.
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, contents creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers.
Additional info regarding BC Residents and
global Investors: Effective September 15 2008 - all BC investors should review
all OTC and Pink sheet listed companies for adherence in new disclosure filings
and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
global Investors: Effective September 15 2008 - all BC investors should review
all OTC and Pink sheet listed companies for adherence in new disclosure filings
and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Learn more about our news, PR and social
media services at Investorideas.com
media services at Investorideas.com
To
learn more about the Investorideas.com podcast series or to sponsor a podcast:
learn more about the Investorideas.com podcast series or to sponsor a podcast:
Contact Investorideas.com
800-665-0411
Investor Ideas #Potcasts #Cannabis News and #Stocks on the Move: TSXV: $N.V, TSXV: $OGI.V, CSE: $MYM.C
Investor Ideas #Potcasts #Cannabis News
and #Stocks on the Move: TSXV: $N.V,
TSXV: $OGI.V, CSE: $MYM.C
Delta, Kelowna, BC –August 24, 2018 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2018/cannabis/08242Potcasts-TSXV-N-OGI-CSE-MYM.asp
Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast – looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today we will be looking at announcements from Namaste Technologies Inc.
trading on the TSX-Venture as N, Organigram Holdings Inc. trading on the
TSX-Venture as OGI and the OTCQB as OGRMF and MYM Nutraceuticals Inc., trading on the CSE as MYM.
Namaste Technologies Inc. announced that the Company has received
official approval of the latest version of its NamasteMD cannabis telemedicine
App for Google Android devices, which is live in the Google Play store as of 8
AM EST August 23rd, 2018. Approximately 50% of mobile phone users in
Canada use Android devices. With the new launch of the apps on both iOS and
Android platforms, NamasteMD can now facilitate online patient consultations,
free of charge, within 15 minutes from sign-up on the App. The Company
anticipates launching real-time consultations through NamasteMD within the next
10 days. Further to the Company's Aug 22nd news release, NamasteMD
has achieved over 14,000 registered users, representing a 130% increase over a
2-month period. The Company anticipates significant acceleration in conversion
rates with additional exposure through the Google Play store.
Namaste has developed Canada's first fully-compliant medical cannabis
patient portal, available on iPhone or Android devices, which allows Namaste to
acquire patients faster and at a lower cost in comparison with other Licensed
Producers. Patients acquired through NamasteMD have access to purchase medical
cannabis through Namaste's cultivation partners. Under the terms of various
Educational Service Agreements, Namaste collects between 15-20% of the gross
revenue derived from patient purchasing through referrals to Licensed Producers
under NamasteMD. Namaste is presently partnered with over 10 Licensed
Producers.
With Namaste's medical cannabis "sales-only" license imminent,
the Company anticipates a sharp increased revenue and margin with Cannmart
booking full revenue amounts from patient ordering and the Company will aim to
maintain a minimum of a 50% gross margin on cannabis products sold directly on
its website.
Organigram Holdings Inc., the parent company of Organigram Inc, a
leading licensed producer of medical marijuana, announced that the Company has
signed a supply agreement with Nova Scotia Liquor Corporation (NSLC) in
anticipation of the launch of a legal, adult use recreational cannabis market
in the province.
"We are pleased to announce our supply agreement with NSLC,"
says Greg Engel, Organigram's Chief Executive Officer. "Our home markets
have always been a key priority for Organigram and this announcement solidifies
our position as the market leader here in the Maritimes. With supply
arrangements in place in six provinces, we take great pride in our place as a
national leader working towards a responsible, sustainable and successful
adult-use recreational cannabis market."
MYM Nutraceuticals Inc., announced that it has
entered into a partnership with the University of Sherbrooke to study the
medicinal and industrial uses of cannabis and hemp. Researchers at the
University of Sherbrooke will work with an on-site coordinator to create
partnerships by targeting expertise in various faculties and training centres.
During cannabis prohibition, research on its compounds and by-products
remained very limited. This partnership aims to explore the benefits of the
cannabis plant. "Université de Sherbrooke groups together a broad set
of skills in relation to the opportunities associated with cannabis," said
Vincent Aimez, Vice-President, Commercialization and Partnerships, University
of Sherbrooke. "MYM's contribution will help actively explore multiple research
projects. This is a completely new and highly promising multidisciplinary
partnership we wish to nurture and grow in the coming years."
Avenues of collaboration range from identifying the best alternative
energy systems in greenhouses to the effects of cannabinoids on the nervous and
immune systems. Research will also include: industrial materials manufacturing,
eco materials, hemp fiber biofuels and opportunities created from the
by-products of cannabis production.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Spotify, Google Play Music,
Stitcher, Spreaker, YouTube via
Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Investing Ideas
Investorideas.com is a recognized news source
publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and
stock news column, Investor
Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the Stock Guru daily podcast on Support and Resistance Trading.
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for adherence
in new disclosure filings and filing appropriate documents with Sedar. Read for
more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Do you trade or invest in Marijuana / Hemp
Stocks? Check out our stock directory of
publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX
Marijuana / Hemp Stocks
Join our Group on Linkedin and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing
Thursday, August 23, 2018
Investor Ideas #Potcasts #Cannabis News and #Stocks on the Move: TSX: $WEED.TO, CSE: $CHOO,C, CSE: $CRZ.C, TSX: $VFF.TO, TSXV: $EMH.V, CSE: $HUGE.C
Investor Ideas #Potcasts #Cannabis News
and #Stocks on the Move: TSX: $WEED.TO,
CSE: $CHOO,C, CSE: $CRZ.C, TSX: $VFF.TO, TSXV: $EMH.V, CSE: $HUGE.C
Delta, Kelowna, BC –August 23, 2018 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2018/cannabis/08231Potcasts-TSX-WEED-CSE-CHOO-CRZ-VFF-EMH-HUGE.asp
Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast ; looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today we will be looking at announcements from Choom™ (CSE:
CHOO & OTCQB:CHOOF), CannaRoyalty Corp.(CSE: CRZ) , Village Farms International,
Inc. (TSX: VFF and OTC: VFFIF), Emerald Health Therapeutics,
Inc. ( TSX-Venture: EMH) , Canopy Growth
Corporation (TSX: WEED and NYSE:CGC ) and FSD Pharma Inc. (CSE: HUGE and OTC: FSDDF).
Choom™ an emerging, fully-integrated cannabis company,
announced that it has advanced its retail portfolio and the build-out of its
cannabis retail store network in Alberta and British Columbia.
Choom has secured the rights to an additional 5 retail locations in
Alberta and 7 in B.C. These new retail opportunities bring Choom's total retail
potential up to 52 locations across western Canada. Choom's rapidly expanding
provincial presence now stands at 29 leases in highly strategic and secure
locations in Alberta with 28 applications submitted, in combination with 17
retail opportunities in B.C.
CannaRoyalty Corp. today announced the
Company's financial results for the three and six-month periods ended June 30,
2018.
"Q2 marked a turning point for CannaRoyalty and its shareholders as
the team translated strategy and execution into record financial performance.
The Company generated earnings per share of $0.18 primarily by delivering on
its stated objective of rationalizing early passive investments. The Company
also generated a record adjusted EBITDA result for a Canadian-listed cannabis
company2," said Marc Lustig, CEO of CannaRoyalty. "Q2 is
the beginning of a multi-quarter parabolic step change in revenue, powered by
sequential acquisitions and organic growth. CannaRoyalty generated a record
$3.5 million in revenue this quarter, a 446% increase from Q1 and more than the
Company generated in all of 2017. These results reflect the successful
initiation of the Company's strategic focus on building its Californian
distribution and brands platform. This growth is expected to continue in Q3 and
Q4 as FloraCal and RVR are added to the Company's financials and as our team
continues to grow market share and expand the Company's supporting
manufacturing and value-add services footprint. Both RVR and FloraCal are
performing above expectations, and we are actively executing our plans to
increase the revenue generating capacity of both companies. I thank all of our
long term shareholders for their faith in this team and our plan. I am proud to
say that this is truly just the beginning of the CannaRoyalty story."
Some of the financial results highlights included:
·
Q2-2018 Revenue of $3.5
million compared to $643,437 in Q1-2018 – marks the successful initiation of
California distribution and manufacturing strategy.
·
Net income of $9.3 million
(EPS of $0.18) and EBITDA of $10.4 million generated through execution of
stated strategy to rationalize non-core assets and an increase in gross margin
related to growing product sales.
·
FloraCal (closed July 2nd)
and RVR Distribution ("RVR") (closing in Q3-2018) are performing
above plan and are expected to drive sequential revenue growth through the
second half of 2018 and beyond.
·
Premier cannabis brand
development platform powered by five licensed distribution and manufacturing
facilities across California, delivering several of the state's top independent
branded products to the majority of licensed dispensaries in the state.17
Village Farms International, Inc. and Emerald Health Therapeutics,
Inctoday announced that their 50/50 joint venture for large-scale, low-cost,
high-quality cannabis production, Pure Sunfarms, received from Health Canada
its third amendment to the cultivation license for its Delta 3 greenhouse in
Delta, BC. This amendment permits Pure Sunfarms to expand its cannabis
production area by 195,000 square feet to approximately 420,000 square feet of
the 1.1-million square foot Delta 3 production facility. The newly licensed
area will be in commercial production this week, as the Delta 3 nursery has
been producing cuttings in anticipation of this expansion.
Pure Sunfarms expects to have the full 1.1 million square foot Delta 3
facility, one of the single largest cannabis growing facilities in the world,
converted for cannabis production by year end. The technologically-advanced
Delta 3 greenhouse design is based on decades of large-scale, low-cost
agricultural production experience and extensive cannabis expertise, resulting
in a state-of-the-art facility with 17 grow rooms (seven of which are now
licensed) optimized for year-round harvesting (more than 85 harvests annually)
and an automated process line encompassing harvesting, trimming, drying and
packaging.
Canopy Rivers Corporation, the venture capital investment platform of
Canopy Growth Corporation, announced that it has set a date of September 12,
2018, for its upcoming shareholder meeting in connection with the proposed
business combination involving AIM2 Ventures Inc. and Canopy Rivers.
As previously announced, Canopy Rivers has entered into a definitive
amalgamation agreement with AIM2, which outlines the terms and conditions
pursuant to which the parties will complete the Go Public Transaction. The Go
Public Transaction will result in a reverse take-over of AIM2 by Canopy Rivers
and will constitute AIM2's "Qualifying Transaction" under Policy 2.4
– Capital Pool Companies of the
TSXV Corporate Finance Manual.
Subject to receipt of all required approvals, including the final
approval of the TSX Venture Exchange, the Go Public Transaction is expected to
close and the subordinated voting shares of the resulting issuer are expected
to commence trading on the TSXV under the symbol "RIV" during the
week of September 17, 2018.
FSD Pharma Inc. reported today that its strategic R&D partner,
SciCann Therapeutics Inc., has achieved positive results in a pre-clinical
efficacy study of its proprietary "Steady Stomach" CBD combination
product for Inflammatory Bowel Disease (IBD). Under the terms of the agreement
between FSD and SciCann, FSD Pharma holds exclusive marketing and distribution
rights for the "Steady Stomach" product in Canada.
The "Steady Stomach" product is a patent-pending combination
of Cannabidiol (CBD) together with additional synergistic factors that potentiate
and activate the anti-inflammatory properties of CBD, thus making it more
effective as a potential treatment for IBD disorders. All active ingredients of
the "Steady Stomach" formulation are natural food-grade compounds,
thus qualifying it as a CBD food supplement product. Previously completed tox
studies in rodents performed by SciCann has demonstrated very high safety
profile for the combination product, without any observed adverse events.
The pre-clinical study used a gold standard rodent model of Ulcerative
Colitis, and demonstrated a significant 3-fold improved efficacy for the
combination product, as compared to CBD alone, in reversing the deleterious
effects caused by the colitis induction agent in the study model. Specifically,
while the CBD alone arm achieved only a 27% improvement score as compared to
the non-treated control arm, the "Steady Stomach" combination
treatment arm achieved a 79% improvement score, thus almost completely
alleviating the Colitis symptoms induced in the model animals.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Spotify, Google Play Music,
Stitcher, Spreaker, YouTube via
Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Investing Ideas
Investorideas.com is a recognized news source
publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and
stock news column, Investor
Ideas #Potcasts #Cannabis News and
Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the Stock Guru daily podcast on Support and Resistance Trading.
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Do you trade or invest in Marijuana / Hemp
Stocks? Check out our stock directory of
publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX
Marijuana / Hemp Stocks
Join our Group on Linkedin and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing
#Cannabisstocks - Canopy Rivers Updates Upcoming Go Public Transaction; Venture capital investment platform of Canopy Growth (TSX: $WEED. TO) (NYSE: $CGC)
#Cannabisstocks - Canopy Rivers Updates Upcoming Go
Public Transaction; Venture capital investment platform of Canopy Growth
(TSX: $WEED. TO) (NYSE: $CGC)
TORONTO, ON - August 23, 2018 – (Investorideas.com Newswire)
Canopy Rivers Corporation ("Canopy Rivers"), the venture capital
investment platform of Canopy Growth Corporation (TSX:
WEED) (NYSE: CGC)
("Canopy Growth"), is pleased to announce that it has set a date of
September 12, 2018, for its upcoming shareholder meeting in connection with the
proposed business combination involving AIM2 Ventures Inc. ("AIM2")
and Canopy Rivers (the "Go Public Transaction").
Read this in full at http://www.investorideas.com/news/2018/cannabis/08233TSXWEED.asp
As previously announced, Canopy Rivers has entered
into a definitive amalgamation agreement with AIM2, which outlines the terms
and conditions pursuant to which the parties will complete the Go Public
Transaction. The Go Public Transaction will result in a reverse take-over of
AIM2 by Canopy Rivers and will constitute AIM2's "Qualifying
Transaction" under Policy 2.4 – Capital Pool Companies of the TSXV
Corporate Finance Manual.
Subject to receipt of all required approvals,
including the final approval of the TSX Venture Exchange (the
"TSXV"), the Go Public Transaction is expected to close and the
subordinated voting shares of the resulting issuer are expected to commence
trading on the TSXV under the symbol "RIV" during the week of
September 17, 2018.
"With Canopy Rivers, we are well-positioned to
take advantage of the universe of investment opportunities unfolding globally
in the ever-expanding cannabis economy," said Bruce Linton, Chairman and
acting CEO of Canopy Rivers, and co-CEO of Canopy Growth. "The strategic
relationship with Canopy Growth, strong management and access to capital will
enable Canopy Rivers to build upon a proven track record and continue to
develop a leading ecosystem of cannabis companies across the entire cannabis
value chain."
To date, Canopy Rivers has made investments in eleven
domestic and international companies, establishing a diversified portfolio of
licensed producers, late stage licensed producer applicants, pharmaceutical
formulators, brand developers and distributors, retail networks, and technology
and media platforms.
As previously announced, subject to the satisfaction
of certain escrow release conditions, the net proceeds from Canopy Rivers' $104
million subscription receipt financing are expected to be released from escrow
in connection with the closing of the Go Public Transaction. The oversubscribed
private placement, which was co-led by CIBC Capital Markets, GMP Securities
L.P. and Eight Capital, on behalf of a syndicate of agents including Cormark
Securities Inc., INFOR Financial Inc. and PI Financial Corp., closed on July 6,
2018.
About Canopy Rivers:
Canopy Rivers is a unique investment and operating
platform structured to pursue investment opportunities in the emerging global
cannabis sector. Canopy Rivers works collaboratively with Canopy Growth
(TSX:WEED, NYSE: CGC) to identify strategic counterparties seeking
financial and/or operating support. Canopy Rivers has developed an investment
ecosystem of complementary cannabis operating companies that represent various
segments of the value chain across the emerging cannabis sector. As the
portfolio continues to develop, constituents will be provided with
opportunities to work with Canopy Growth and collaborate among themselves,
which Canopy Rivers believes will maximize value for its shareholders and foster
an environment of innovation, synergy and value creation for the entire
ecosystem.
Cautionary Note Regarding Forward-Looking Information
This press release contains statements which
constitute "forward-looking information" within the meaning of
applicable securities laws, including statements regarding the plans,
intentions, beliefs and current expectations of Canopy Rivers with respect to
future business activities and operating performance. Forward-looking
information is often identified by the words "may",
"would", "could", "should", "will",
"intend", "plan", "anticipate",
"believe", "estimate", "expect" or similar
expressions and includes information regarding: the timing for the closing of
the Go Public Transaction and the commencement of trading of the subordinated
voting shares of the resulting issuer; the timing and anticipated release of
the net proceeds from the subscription receipt financing; Canopy Rivers'
position and opportunity in the cannabis economy; the ability to build a
leading ecosystem of cannabis companies; and the expected benefits to be
obtained by Canopy Rivers' portfolio companies. Investors are cautioned that
forward-looking information is not based on historical facts but instead
reflect Canopy Rivers' management's expectations, estimates or projections
concerning future results or events based on the opinions, assumptions and
estimates of management considered reasonable at the date the statements are
made. Although Canopy Rivers believes that the expectations reflected in such forward-looking
information are reasonable, such information involves risks and uncertainties,
and undue reliance should not be placed on such information, as unknown or
unpredictable factors could have material adverse effects on future results,
performance or achievements of the combined company. Among the key factors that
could cause actual results to differ materially from those projected in the
forward-looking information are the following: the ability to consummate the Go
Public Transaction; possible termination of the amalgamation agreement; the
ability to obtain requisite regulatory and shareholder approvals and the
satisfaction of other conditions to the consummation of the Go Public
Transaction on the proposed terms and schedule; the potential impact of the
announcement or consummation of the Go Public Transaction on relationships,
including with regulatory bodies, employees, suppliers, customers and
competitors; the re-rating potential following the consummation of the Go
Public Transaction; changes in general economic, business and political
conditions, including changes in the financial markets; changes in applicable
laws, including the approval and implementation of the Cannabis Act; compliance
with extensive government regulation; and the diversion of management time on
the Go Public Transaction. This forward-looking information may be affected by
risks and uncertainties in the business of Canopy Rivers and market
conditions.
Should one or more of these risks or uncertainties
materialize, or should assumptions underlying the forward-looking information
prove incorrect, actual results may vary materially from those described herein
as intended, planned, anticipated, believed, estimated or expected. Although
Canopy Rivers has attempted to identify important risks, uncertainties and
factors which could cause actual results to differ materially, there may be
others that cause results not to be as anticipated, estimated or intended.
Canopy Rivers does not intend, and does not assume any obligation, to update
this forward-looking information except as otherwise required by applicable
law.
SOURCE Canopy Rivers
For further information: Canopy Rivers Corporation,
Daniel Pearlstein, Executive Vice President, Strategy, Canopy Rivers
Corporation, daniel@canopyrivers.com,
647-475-1115
This
news is published on the Investorideas.com Newswire - a global digital news
source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital
publisher of third party sourced news, articles and equity research as well as
creates original content, including video, interviews and articles. Original
content created by investorideas is protected by copyright laws other than
syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release on the Investorideas.com newswire http://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors:
Effective September 15 2008 - all BC investors should review all OTC and Pink
sheet listed companies for adherence in new disclosure filings and filing
appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp
Marijuana / Hemp Stocks
Like Marijuana / Hemp Stocks? View our Marijuana / Hemp
Stocks Directory
Join our Group on Linkedin - Marijuana / Hemp
Stocks - News and Trends in Green Investing
Global Cannabis
Investing - features Investor Ideas Cannabis news
Subscribe to:
Posts (Atom)